NextPlat (NXPL) Operating Leases (2019 - 2026)
NextPlat's (NXPL) quarterly Operating Leases came in at $576000.0 in Q2 2026, up 110.22% year-over-year from $274000.0 in Q2 2025, and down 10.14% quarter-over-quarter from $641000.0 in Q1 2026.
Analysis
NextPlat (NXPL) Operating Leases (2019 - 2026) Analysis & Trends
NextPlat (NXPL) has reported Operating Leases for 8 consecutive years, with $576000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Operating Leases rose 110.22% year-over-year to $576000.0 in Q2 2026; TTM through Jun 2026 was $576000.0, a 110.22% increase from a year earlier, with the FY2025 full-year figure at $41000.0, down 90.64% from the prior year.
- Operating Leases was $576000.0 for Q2 2026 at NextPlat, down from $641000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $929000.0 in Q4 2023 and troughed at $41000.0 in Q4 2025.
- A 5-year average of $574858.4 and a median of $607720.0 in 2023 frame the typical range for Operating Leases.
- Across the five-year window, Operating Leases soared 13326.63% in 2022 and plunged 90.64% in 2025, its largest moves.
- Over 5 years, Operating Leases stood at $650000.0 in 2022, then jumped by 42.92% to $929000.0 in 2023, then slumped by 52.85% to $438000.0 in 2024, then sank by 90.64% to $41000.0 in 2025, then surged by 1304.88% to $576000.0 in 2026.
- The last three Operating Leases figures came in at $576000.0 (Q2 2026), $641000.0 (Q1 2026), and $41000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 576,000.00 |
| Mar 31, 2026 | 641,000.00 |
| Dec 31, 2025 | 41,000.00 |
| Sep 30, 2025 | 197,000.00 |
| Jun 30, 2025 | 274,000.00 |
| Mar 31, 2025 | 351,000.00 |
| Dec 31, 2024 | 438,000.00 |
| Sep 30, 2024 | 553,000.00 |
| Jun 30, 2024 | 619,000.00 |
| Mar 31, 2024 | 853,000.00 |
| Dec 31, 2023 | 929,000.00 |
| Sep 30, 2023 | 712,521.00 |
| Jun 30, 2023 | 567,071.00 |
| Mar 31, 2023 | 607,720.00 |
| Dec 31, 2022 | 650,000.00 |
| Sep 30, 2022 | 863,294.00 |
| Jun 30, 2022 | 899,987.00 |
| Dec 31, 2021 | 19,763.00 |
| Jun 30, 2021 | 6,703.00 |
| Mar 31, 2021 | 14,725.00 |